XUNFEIHEALTH (02506) Sets 27 March 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express
03/17

Xunfei Healthcare Technology Co., Ltd. (stock code: 02506) announced that its board of directors will convene on 27 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes consideration of a final dividend recommendation and other routine matters.

The current board comprises one executive director—Dr. Tao Xiaodong—three non-executive directors, and three independent non-executive directors. The announcement, dated 17 March 2026, was issued under the name of Executive Director Dr. Tao Xiaodong.

No additional financial figures or dividend details were disclosed in the notice. The company will publish the audited FY2025 results following the board’s approval.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10